Erratum: Dysregulated survivin expression in nasal polyps of individuals with aspirin exacerbated respiratory disease (American Journal of Rhinology and Allergy (2012) 26, (380-384) DOI: 10.2500/ajra.2012.26.3802);Dysregulated survivin expression in nasal polyps of individuals with aspirin exacerbated respiratory disease

American Journal of Rhinology and Allergy

Volumn 26, Issue 5, 2012, Pages 380-384

  Fruth, Kai ^a   Schramek, Eduard ^a   Docter, Dominic ^a   Haxel, Boris R ^a   Schneider, Astrid ^b   Mann, Wolf J ^a   Brieger, Juergen ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVIN; VASCULOTROPIN;

ADULT; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; MALE; NOSE MUCOSA; NOSE POLYP; PROTEIN EXPRESSION;

EID: 84866310599     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2012.26.3826     Document Type: Erratum

References (23)

1. Farajzadeh Deroee A, Oweinah J, Naraghi M, et al. Regression of polypoid nasal mucosa after systemic corticosteroid therapy: A proteomics study. Am J Rhinol Allergy 23:480-485, 2009.
2. Lee RU, and Stevenson DD. Aspirin-exacerbated respiratory disease: Evaluation and management. Allergy Asthma Immunol Res 3:3-10, 2011.
3. Amar YG, Frenkiel S, and Sobol SE. Outcome analysis of endoscopic sinus surgery for chronic sinusitis in patients having Samtera's triad. J Otolaryngol 29:7-12, 2000. (Pubitemid 30120552)
4. Mendelsohn D, Jeremic G, Wright ED, and Rotenberg BW. Revision rates after endoscopic sinus surgery: A recurrence analysis. Ann Otol Rhinol Laryngol 120:162-166, 2011.
5. Pawliczak R, Lewandowska-Polak A, and Kowalski ML. Pathogenesis of nasal polyps: an update. Curr Allergy Asthma Rep 5:463-471, 2005. (Pubitemid 41683970)
6. Gosepath J, Schafer D, and Mann WJ. Aspirin sensitivity: Long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day. Laryngorhinootologie 81:732-738, 2002. (Pubitemid 35350952)
7. Knauer SK, Bier C, Schlag P, et al. The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle 6:1502-1509, 2007.
8. Li D-W, Gao S, Shen B, et al. Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma. Med Oncol 28(suppl 1):S333-S3340, 2011.
9. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3:46-54, 2003. (Pubitemid 37328886)
10. Qiu Z-F, Han D-M, Zhang L, et al. Expression of survivin and enhanced polypogenesis in nasal polyps. Am J Rhinol 22:106-110, 2008. (Pubitemid 351570547)
11. Cho SH, Lee SH, Kim KR, et al. Expression and distributional patterns of the inhibitor of apoptosis protein family and caspase 3 in nasal polyps. Arch Otolaryngol Head Neck Surg 134:316-321, 2008. (Pubitemid 351439262)
12. Park SK, Kim HI, Yang YI, et al. Effects of methotrexate on vascular endothelial growth factor, angiopoietin 1, and angiopoietin 2 in nasal polyps. Am J Rhinol Allergy 25:129-132, 2011.
13. Gosepath J, Brieger J, Lehr HA, and Mann WJ. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps. Am J Rhinol 19:7-13, 2005. (Pubitemid 40443998)
14. Hu KH, Lee FP, Cheng YJ, and Huang HM. Vascular endothelial growth factor and children featuring nasal polyps. Int J Pediatr Otorhinolaryngol 71:23-28, 2007.
15. Lee C-C, Chen S-C, Tsai S-C, et al. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells. J Biomed Sci 13:143-156, 2006. (Pubitemid 43162512)
16. Tran J, Rak J, Sheehan C, et al. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 264:781-788, 1999.
17. Fokkens W, Lund V, and Mullol J. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 45:97-101, 2007.
18. Selivanova O, Brieger J, Heinrich UR, and Mann W. Akt and c-Jun N-terminal kinase are regulated in response to moderate noise exposure in the cochlea of guinea pigs. ORL J Otorhinolaryngol Relat Spec 69:277-282, 2007. (Pubitemid 47360930)
19. Knauer SK, Carra G, and Stauber RH. Nuclear export is evolutionarily conserved in CVC paired-like homeobox proteins and influences protein stability, transcriptional activation, and extracellular secretion. Mol Cell Biol 25:2573-2582, 2005. (Pubitemid 40385134)
20. Plataki M, Koutsopoulos AV, Darivianaki K, et al. Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 127:266-274, 2005. (Pubitemid 41724587)
21. Souza HS, Tortori CJ, Castelo-Branco MT, et al. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: Evidence of altered expression of FasL and perforin cytotoxic pathways. Int J Colorectal Dis 20:277-286, 2005. (Pubitemid 40558036)
22. Schimmer AD. Inhibitor of apoptosis proteins: Translating basic knowledge into clinical practice. Cancer Res 64:7183-7190, 2004. (Pubitemid 39372048)
23. Picado C, Fernandez-Morata JC, Juan M, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 160:291-296, 1999. (Pubitemid 29326102)